Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
64,213,019
-
Shares change
-
+3,021,507
-
Total reported value, excl. options
-
$2,865,901,646
-
Value change
-
+$125,294,621
-
Put/Call ratio
-
23%
-
Number of buys
-
105
-
Number of sells
-
-101
-
Price
-
$44.61
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2020
251 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2020.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,213,019 shares
of 80,437,135 outstanding shares and own 80% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6,238,168 shares), VANGUARD GROUP INC (5,579,171 shares), FRANKLIN RESOURCES INC (5,520,582 shares), BlackRock Inc. (5,127,914 shares), FMR LLC (4,878,225 shares), RTW INVESTMENTS, LP (3,932,746 shares), STATE STREET CORP (2,372,677 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,052,837 shares), JANUS HENDERSON GROUP PLC (1,769,757 shares), and GREAT POINT PARTNERS LLC (1,763,387 shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.